Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection

by Ouli Xie, Kathryn Cisera, Lucy Taylor, Carly Hughes, Benjamin Rogers
Published 2020-11-01